HU

Hospital Universitari i Politècnic La Fe at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitari i Politècnic La Fe takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on oncology nursing, including building the future workforce and equitable health care for underserved populations. It also covers the challenges of caring for children with cancer, with a focus on transitions in palliative care.

OrganizationESMO 2026 Attendance
HU
Hospital Universitari i Politècnic La Fe
Valencia, Spain
Cancer centre & hospital
Public university hospital of the Valencian regional health service in Valencia, Spain.
Chair
Sat Oct 24
10:15–11:30
Workforce development for the future
with New Cross Hospital
Nursing & supportive care
Chair
Sun Oct 25
10:15–11:30
Equitable health care of underserved population
with Aston University
Nursing & supportive care
Chair
Sun Oct 25
13:30–15:00
EONS Working Groups: Sofa conversation with WG chairs on acheivements
with Clinical Hospital Centre Osijek
Nursing & supportive care
Talk
Mon Oct 26
10:00–10:05
Opening remarks
SIOPE challenges in children cancer care · with The Open University
Nursing & supportive care
Chair
Mon Oct 26
10:00–11:00
SIOPE challenges in children cancer care
with The Open University
Nursing & supportive care
Talk
Mon Oct 26
10:05–10:20
Transitions in palliative care
SIOPE challenges in children cancer care
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Universitari i Politècnic La Fe

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction